ReviewCureus2025
Methods for Pluripotent Stem Cell Characterization: A Narrative Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Structure Variations and 3D Genome Disruption: Implications in Safety of hPSC-Based Cell Therapy.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pluripotent stem cells (PSCs) have revolutionized medical research by offering significant advancements in regenerative medicine, disease modeling, and drug discovery. Several research and clinical studies have successfully generated PSCs but with varying characterization methodologies. Characterization methods are crucial to guarantee the safety and efficacy of PSCs in research and therapeutic applications. Therefore, there is a need for standardization of characterization methods to ensure their quality, reproducibility, and comparability across laboratories. In this review, the authors discuss the mandatory and non-mandatory assessments used for morphological, molecular, genetic, and functional PSC characterization. We will present their advantages and limits with the aim of providing insights for assessment optimization and helping facilitate the standardization of characterization methods.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.